Accelerating protein production with high reproducibility is a key challenge in drug discovery and development. In this webinar, Karthik Rajasekar from Evotec department of Protein Sciences will ...
Biopharma’s ongoing quest to develop COVID-19 drugs and vaccines, plus growing industry demand for producing various types of new therapies, are fueling the $1.5-billion expansion of manufacturing ...
Cytiva says it will spend $600 million to build its first chromatography resin plant outside Sweden. The company, owned by Danaher, has acquired a facility in Muskegon, Michigan, that it will retrofit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results